Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (191-200 of 233) with videos related to

Pageof 24
Sort By:
Blood|May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma projectJan Delabie, Harald Holte, Julie M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy studyPier Paolo Piccaluga, Fabio Fuligni, Antonio De Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 TrialMarc P E André, Théodore Girinsky, Massimo Federico, et al.
Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.
Blood|December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL ConsortiumMark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2010
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution studyClaudia Allemani, Hans Storm, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working groupFrancesco Sardanelli, Carla Boetes, Bettina Borisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II TrialLuc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, et al.
The Lancet. Haematology|February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell ProjectChristopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Pageof 24

Showing results (191-200 of 233) with videos related to

Sort By:
Pageof 24
Blood|May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma projectJan Delabie, Harald Holte, Julie M Vose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy studyPier Paolo Piccaluga, Fabio Fuligni, Antonio De Leo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12Michael Crump, John Kuruvilla, Stephen Couban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2017
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 TrialMarc P E André, Théodore Girinsky, Massimo Federico, et al.
Blood Cancer Journal|January 9, 2026
Genome-wide association study of event-free survival in follicular lymphoma patients treated with front-line immunochemotherapyHervé Ghesquières, Youenn Drouet, Susan L Slager, et al.
Blood|December 5, 2025
Early time to relapse as a survival prognosticator in mature T-cell/NK-cell lymphomas: results from the PETAL ConsortiumMark N Sorial, Luis Malpica, Carlos Sergio Chiattone, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2010
Variation in 'standard care' for breast cancer across Europe: a EUROCARE-3 high resolution studyClaudia Allemani, Hans Storm, Adri C Voogd, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working groupFrancesco Sardanelli, Carla Boetes, Bettina Borisch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2022
Brentuximab Vedotin Plus AVD for First-Line Treatment of Early-Stage Unfavorable Hodgkin Lymphoma (BREACH): A Multicenter, Open-Label, Randomized, Phase II TrialLuc-Matthieu Fornecker, Julien Lazarovici, Igor Aurer, et al.
The Lancet. Haematology|February 28, 2020
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell ProjectChristopher P Fox, Monica Civallero, Young-Hyeh Ko, et al.
Pageof 24